NDC 50474-150

Tussionex Pennkinetic

Hydrocodone And Chlorpheniramine

Tussionex Pennkinetic is a Oral Suspension, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ucb Inc.. The primary component is Hydrocodone; Chlorpheniramine.

Product ID50474-150_2c46faa3-aa31-4cfd-926d-8805a3149851
NDC50474-150
Product TypeHuman Prescription Drug
Proprietary NameTussionex Pennkinetic
Generic NameHydrocodone And Chlorpheniramine
Dosage FormSuspension, Extended Release
Route of AdministrationORAL
Marketing Start Date1987-12-31
Marketing End Date2019-06-30
Marketing CategoryNDA / NDA
Application NumberNDA019111
Labeler NameUCB Inc.
Substance NameHYDROCODONE; CHLORPHENIRAMINE
Active Ingredient Strength10 mg/5mL; mg/5mL
Pharm ClassesOpioid Agonist [EPC],Opioid Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
DEA ScheduleCII
NDC Exclude FlagN

Packaging

NDC 50474-150-49

1 BOTTLE, PLASTIC in 1 CARTON (50474-150-49) > 115 mL in 1 BOTTLE, PLASTIC
Marketing Start Date1987-12-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50474-150-49 [50474015049]

Tussionex Pennkinetic SUSPENSION, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA019111
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1987-12-31
Marketing End Date2019-06-30

Drug Details

Active Ingredients

IngredientStrength
HYDROCODONE10 mg/5mL

OpenFDA Data

SPL SET ID:25f2815d-978c-4043-88bd-fa5e556f8bc7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1087459
  • 1087463
  • Pharmacological Class

    • Opioid Agonist [EPC]
    • Opioid Agonists [MoA]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "Tussionex Pennkinetic" or generic name "Hydrocodone And Chlorpheniramine"

    NDCBrand NameGeneric Name
    50474-150Tussionex Pennkinetichydrocodone and chlorpheniramine
    53014-548Tussionex Pennkinetichydrocodone polistirex and chlorpheniramine polistirex

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.